saxagliptin

noun

sax·​a·​glip·​tin ˌsak-sə-ˈglip-tən 

: a hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes

Note: Saxagliptin acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze.